EQT Life Sciences is a venture capital firm that invests in innovative medicines, devices, and tools in the life sciences industry.

EQT Life Sciences

Domain Not Resolving

Google Tag Manager

Google Font API

DNSSEC

Amazon

Font Awesome

IPv6

CrUX Dataset

Cloudflare JS

CDN JS

Merijn Klaassen

Managing Director

Cillian King

Business Controller

Koen Sintnicolaas

Legal

Bas Vaessen

General Partner

Fouad Azzam

Legal Counsel

Gisela Wolf

Officemanager

Suzanne Dwinger

René Kuijten

Susanne Waldherr

Office Manager

Joep Muijrers

Ellen Cordo

Chief Finance

Pauline Bieringa

Chairman

Joachim Rothe

Anne Portwich

Partner

Chief Financial Officer

Mark Wegter

Managing Partner

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Merus is a biomedical company engaged in the discovery and development of antibody-based biopharmaceuticals.

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

Late Stage Venture Investors with Investments in Switzerland

Noord-Holland Investors

Venture Stage Investors with Investments in Oxfordshire

Investors Active in Rhone-Alpes

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

LSP Dementia Fund

LSP 6

LSP Health Economics Fund 2

Life Sciences Partners 5 FUND

LSP Health Economics Fund

Amsterdam

Noord-Holland

The Netherlands

Europe

ATB Therapeutics: Biologics Company Raises €54 Million (Series A)

ATB Therapeutics Raises €54M in Series A Funding

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

FR0000121121

Evommune Secures $115M Series C Financing to Advance Clinical Development

European VC Funding Drops To Lowest Quarter In 4 Years, Despite Uptick For German Startups

HTML5

Apache Server

jQuery

Microsoft Outlook

Google Analytics

Cloudflare CDN

EQT Life Sciences owns LSP BioVentures

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

European Biotech Acquisition Corp.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 5, 2024 5:59 PM	7657edbb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	296769cd
crunchbase profile	general	Nov 25, 2024 9:33 AM	2c313092
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:02 PM	87d414dd
peers	general	Aug 5, 2024 5:59 PM	31e6d0f9
news basic	general	Aug 5, 2024 5:59 PM	0510778e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EBAC

COM:LSPVC

EQT Life Sciences

Last Close

11.71

02/03 21:00

Market Cap

183.50M

Beta: -

Volume Today

77.64K

Avg: -